Subramaniam Mahalakshmi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Subramaniam Mahalakshmi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Chinnaswamy Appunu
Division of Crop Improvement, ICAR-Sugarcane Breeding Institute, Coimbatore, India
2 shared publications - Murugavelu Girija Sangari
Department of Botany, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, India
2 shared publications - S. R. Harish Chandar
Division of Crop Improvement, ICAR-Sugarcane Breeding Institute, Coimbatore 641007, Tamil Nadu, India
2 shared publications - Gunasekaran Sinduja1 shared publication
- Janarthanan Aparna
Division of Crop Improvement, ICAR-Sugarcane Breeding Institute, Coimbatore, India
1 shared publication - Molabanti Vasupriya1 shared publication
Latest Publications
- 30 January 2025
- Published by Springer Nature in Tropical Plant Biology
- Vol. 18 (1) , 1-16
Isolation, Genome-Wide Identification and Expression Profiling of CYC/TB1 Like Transcription Factor from Saccharum Complex Under Water Deficit Stress Condition
- 30 January 2025
- Published by Springer Nature in Tropical Plant Biology
- Vol. 18 (1) , 1-16
Isolation, Genome-Wide Identification and Expression Profiling of CYC/TB1 Like Transcription Factor from Saccharum Complex Under Water Deficit Stress Condition
- 2 April 2024
- Published by Springer Nature in Sugar Tech
- Vol. 27 (1) , 179-192
Isolation, Characterization and Genome-Wide Identification of Cys-2/His-2 Type Zinc Finger Nuclease, a Transcription Activator in Saccharum Complex Under Abiotic Stress Conditions
- 2 April 2024
- Published by Springer Nature in Sugar Tech
- Vol. 27 (1) , 179-192
Isolation, Characterization and Genome-Wide Identification of Cys-2/His-2 Type Zinc Finger Nuclease, a Transcription Activator in Saccharum Complex Under Abiotic Stress Conditions
- Open Access
- 15 November 2023
- Published by IntechOpen
Trending Advancements in Technologies Pertinent to Therapeutical Pharmacodynamics
It is omniscient that pharmacodynamics of a drug is understood as its effect on body by interacting with the structure of targets to either activate or inhibit their function/action. Based on the activity of the drug to the target binding site they have been classified into different types. Physiological, cellular, molecular, biochemical, and toxicological effects individually have a significant role in drug’s effect and response. The mechanism of action, dosage and its response, therapeutic index are some of the noteworthy parameters to be considered in drug pharmacodynamics. This chapter comprehends the above-mentioned concepts, their importance in pharmacodynamics of drug, and the impact of recently developed methods like genome-wide or transcriptome-wide sequencing, chronopharmacodynamics, systems biology, pharmacometabolomics, etc., in different stages of drug discovery process, and how the digitization of therapeutics and healthcare direct the path to personalized medicine. The integration of bioinformatics, systems biology, and big data related approaches like ML & AI with the pharmacological (PK/PD) study highly benefits the patients’ therapeutics.
- 15 November 2023
- Published by IntechOpen
Open AccessTrending Advancements in Technologies Pertinent to Therapeutical Pharmacodynamics
It is omniscient that pharmacodynamics of a drug is understood as its effect on body by interacting with the structure of targets to either activate or inhibit their function/action. Based on the activity of the drug to the target binding site they have been classified into different types. Physiological, cellular, molecular, biochemical, and toxicological effects individually have a significant role in drug’s effect and response. The mechanism of action, dosage and its response, therapeutic index are some of the noteworthy parameters to be considered in drug pharmacodynamics. This chapter comprehends the above-mentioned concepts, their importance in pharmacodynamics of drug, and the impact of recently developed methods like genome-wide or transcriptome-wide sequencing, chronopharmacodynamics, systems biology, pharmacometabolomics, etc., in different stages of drug discovery process, and how the digitization of therapeutics and healthcare direct the path to personalized medicine. The integration of bioinformatics, systems biology, and big data related approaches like ML & AI with the pharmacological (PK/PD) study highly benefits the patients’ therapeutics.